We have previously observed that the phagocytosis of zymosan particles coated with complement by human polymorphonuclear leucocytes is accompanied by a time-and dose-dependent inhibition of phosphatidylcholine synthesis by transmethylation [Garcia Gil, Alonso, Sanchez Crespo & Mato (1981) Biochem. Biophys. Res. Commun. 101, 740-7481. The present studies show that phosphatidylcholine synthesis by a cholinephosphotransferase reaction is enhanced, up to 3-fold, during phagocytosis by polymorphonuclear cells. This effect was tested by both measuring the incorporation of radioactivity into phosphatidylcholine in cells labelled with choline, and by assaying the activity of CDP-choline:diacylglycerol cholinephosphotransferase. The time course of CDP-choline:diacylglycerol cholinephosphotransferase activation by zymosan mirrors the inhibition of phospholipid methyltransferase activity previously reported. The extent of incorporation of radioactivity into phosphatidylcholine induced by various doses of zymosan correlates with the physiological response of the cells to this stimulus. This effect was specific for phosphatidylcholine, and phosphatidylethanolamine turnover was not affected by zymosan. The purpose of this enhanced phosphatidylcholine synthesis is not to provide phospholipid molecules rich in arachidonic acid. The present studies show that about 80% of the arachidonic acid generated in response to zymosan derives from phosphatidylinositol. A transient accumulation of arachidonoyldiacylglycerol has also been observed, which indicates that a phospholipase C is responsible, at least in part, for the generation of arachidonic acid. Finally, isobutylmethylxanthine and quinacrine, inhibitors of phosphatidylinositol turnover, inhibit both arachidonic acid generation and phagocytosis, indicating a function for this pathway during this process.
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PtdCho can be synthesized either by a cholinephosphotransferase reaction or by transmethylation. The first pathway involves the transfer of a phosphocholine group from CDP-choline to a 1,2-diacylglycerol molecule (Kennedy & Weiss, 1956) . The second pathway involves the addition of three methyl groups into the amino group of a PtdEtn molecule, with S-adenosylmethionine as the methyl donor (Bremer & Greenberg, 1961) . The purpose of these two pathways for PtdCho synthesis remains unclear. In rat hepatocytes cyclic AMP Abbreviations used: PtdIns, phosphatidylinositol; PtdA, phosphatidic acid; PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine; lyso-PtdCho, lysophosphatidylcholine; PtdSer, phosphatidylserine; PAF, platelet activating factor; IMX, stimulates PtdCho synthesis by transmethylation (Castanio et a!., 1980 (Castanio et a!., , 1981 and inhibits PtdCho synthesis by a cholinephosphotransferase reaction (Pelech et al., 1981) . Previously we have shown that the addition of opsonized zymosan to human polymorphonuclear leucocytes inhibits the synthesis of PtdCho by transmethylation (Garcia Gil et al., 1981) . In the present paper we have studied the effect of zymosan addition to human polymorphonuclear cells on PtdCho synthesis by a cholinephosphotransferase reaction and observed (1) an increased incorporation of choline into PtdCho in cells prelabelled with [Me-'4C]choline and (2) an activation of the enzyme CDP-choline:diacylglycerol cholinephosphotransferase (EC 2.7.8.2). In order to know whether the previously reported inhibition of PtdCho synthesis by transmethylation was due to a shortage of the substrate PtdEtn, the effect of zymosan on PtdEtn synthesis in cells labelled with [3-3Hlserine was also studied. Finally, we have studied the effect of zymosan addition on arachidonic acid release by polymorphonuclear cells. Arachidonic acid has been shown to be released by polymorphonuclear cells in response to zymosan (Waite et al., 1949; Walsh et al., 1981) . However, whereas Waite et al. (1949) reported that arachidonic acid was mainly provided by PtdCho hydrolysis, Walsh et al. (1981) [5, 6, 8, 9, 11, 12, 14, choline (2pCi/ml) for 30min at 370C and at the end of this period washed three times. After washing, the cell suspension was resuspended in Hepes buffer at a density of 107 cells per ml and incubated for 15 min at 370C. At the end of this period the cell suspension was stimulated with opsonized zymosan (1 mg/ml) and samples containing 4 x 106 cells were taken at various times, pipetted into precooled tubes and centrifuged 5min at 400g at 4°C. Phospholipids were extracted from the pellet with 2.9 ml of methanol/chloroform/water (10: 10: 9, by vol.), the aqueous phase treated three times with 2 ml of methanol/chloroform (1: 1, v/v) and the pooled organic fraction dried under a stream of N2 at 220C. PtdCho and lyso-PtdCho were quantified after separation by t.l.c. on silica gel-60 plates (Garcia Gil et al., 1980) . [1-3H]Ethanolamine and [3-3Hlserine were added at concentrations of respectively 2,Ci/ml and 20,uCi/ml. After 30min incubation the cell suspension was treated as described above. PtdEtn, PtdCho and PtdSer were quantified after separation by t.l.c. on silica gel-60 plates as described by Garcia Gil et al. (1980) .
Assay of CDP-choline:diacylglycerol cholinephosphotransferase. Polymorphonuclear cells were incubated for 15min at 370C at a density of 107 cells per ml and at the end of this period stimulated with zymosan (2 mg/ml). At various times after stimulation, samples containing 27 x 106 cells were centrifuged for Smin at 400g at 40C in precooled tubes and resuspended in 200,u1 of Tris/HCl (1 M), pH8.5. After sonication for i5s in a Branson B-12 sonifier equipped with microtip set at position 3, the homogenate was incubated at 370C in a medium containing 500mM-Tris/HCI, pH 8.5, 0.5 mM-EGTA, 10mM-MgCI2, 100nM-CDP-choline and 0.S,uCi of CDP-[Me-14C]choline in a final volume of 500,1 (Renooij & Snyder, 1981) . At various times lOO,l samples were pipetted into 2 ml of chloroform/methanol/2 M-HCI (6: 3: 1, by vol.), the organic phase washed three times with 0.5 M-KCI in methanol, dried and counted for radioactivity as described previously (Garcia Gil et al., 1980) . Results are expressed as fmol of [Me-14Clcholine groups transferred/min per 107 cells.
Generation of arachidonic acid and arachidonoyldiacylglycerol in response to zymosan. Polymorphonuclear cells were washed once in Hepes buffer containing 0.25% delipidated albumin and resuspended in the same buffer, containing 0.5,Ci of [3Hlarachidonic acid/ml, at a density of 3 x 107 cells per ml. After 30min incubation at 370C, the cell suspension was washed three times with Hepes buffer containing delipidated albumin and resuspended in the same buffer at a density of 107 cells per ml. After incubation for 15min at 370C, zymosan (2 mg/ml) was added and 1 ml samples were pipetted into tubes containing 3.75 ml of chloroform/methanol (1:2, v/v). Then 1.25ml of chloroform and 1.25 ml of 2 M-KCI, containing 5 mM-EDTA were added to form two phases (Billah et al., 1980 ). The organic phase was then removed, dried under N2 and the labelled lipids were quantified after separation by t.l.c. Neutral lipids were separated in ligroin/diethyl ether/acetic acid (50 :50: 1, by vol.) and phospholipids in chloroform/methanol/acetic acid/0.1 M-sodium borate (Schrey & Rubin, 1979; Billah et al., 1980) .
[1-'4CIOleic acid was added at a concentration of 0.5,Ci/ml. After 30min incubation at 370C, the cell suspension was treated as indicated for arachidonic acid.
Assay (Fig. 3) . PtdCho is the only phos- pholipid labelled under these experimental conditions (results not shown). PtdEtn levels measured by the incorporation of labelled ethanolamine or by the decarboxylation of labelled PtdSer remain unchanged after zymosan addition (Fig. 4) .
Specific production ofarachidonic acid by zymosan
When polymorphonuclear cells labelled with [3Hlarachidonic acid are challenged with zymosan (1 mg/ml) the production of arachidonic acid increases in a time-dependent manner (Fig. 5) .
However, in cells labelled with [1-14C]oleic acid zymosan does not produce oleic acid (Fig. 5) . The production of labelled diacylglycerol is initially increased but decreases at later times after the addition of zymosan (Fig. 6 ). The addition of zymosan (1 mg/ml; 10min incubation) depletes PtdIns (about 25%) and PtdCho (about 14%) of labelled arachidonic acid (Fig. 7) . As the amount of arachidonic acid incorporated into Ptdlns is about 2.5-fold greater than that incorporated into PtdCho (Fig. 7) , these results indicate that 80% of the arachidonic acid generated in response to zymosan originates from PtdIns.
Quinacrine and IMX inhibit the formation of arachidonic acid in response to zymosan Quinacrine (0.1 mM) inhibits by about 50% the zymosan (15min incubation)-induced arachidonic acid formation and phagocytosis (Table 1) phosphodiesterase inhibitor, also inhibits the phagocytic response in human polymorphonuclear leucocytes (Alonso et al., 1982 (Pelech et al., 1981) . PtdEtn levels, measured by the incorporation of labelled ethanolamine or by the decarboxylation of labelled PtdSer, remained unchanged after zymosan addition. These results indicate that the trigger for PtdCho synthesis by a cholinephosphotransferase reaction is not a shortage in the concentration of the substrate of the transmethylation reaction. The purpose of this differential regulation of PtdCho synthesis remains unclear. It has been postulated (Hirata & Axelrod, 1980) that the transmethylation pathway would provide PtdCho molecules rich in arachidonic acid. However, in human polymorphonuclear cells, arachidonic acid is released (Waite et al., 1949; Walsh et al., 1981) , though the synthesis of PtdCho by transmethylation is diminished (Garcia Gil et al., 1981) . A similar situation has been recently reported in thrombin-stimulated platelets (Bell et al., 1978; Shattil et al., 1981) . Our present data, in agreement with those of Walsh et al. (1981) , indicate that about 80% of the arachidonic acid generated in response to zymosan originates from PtdIns turnover. This evidence includes the following.
(1) Zymosan stimulation depletes PtdIns of arachidonic acid. (2) Zymosan stimulation causes a transient accumulation of arachidonoyldiacylglycerol, the product of phospholipase C action. (3) Arachidonic acid release is inhibited by prior treatment of polymorphonuclear cells with IMX, an agent that blocks PtdIns turnover by raising cyclic AMP levels (Lapetina & Cuatrecasas, 1979; Lapetina et al., 1981) . Many tissues exhibit a similar enhanced Ptdlns turnover when stimulated (Michell, 1975) . Previous experiments with labelled inositol and phosphate
Vol. 206 Kornovsky & Wallach, 1961; Sastry & Hokin, 1966; Tou & Stjernholm, 1974) were suggestive of a stimulated PtdIns turnover during phagocytosis in polymorphonuclear leucocytes. Walsh et al. (1981) were not able to detect an increase in arachidonoyldiacylglycerol during zymosan stimulation and therefore concluded that a phospholipase A2 acting on Ptdlns, rather than a phospholipase C, was responsible for arachidonic acid generation. However, these same authors could not detect an increased formation of lyso-Ptdlns, the product of phospholipase A2, after stimulation. The production of arachidonoyldiacylglycerol is transient and about 4-fold lower than that of arachidonic acid, which makes the measurement of this metabolite of Ptdlns difficult. We therefore suggest that both phospholipase A2 and phospholipase C are involved in the generation of arachidonic acid during phagocytosis in human polymorphonuclear cells. Finally, the simultaneous inhibition by quinacrine and IMX, inhibitors of the Ptdlns turnover (Lapetina & Cuatrecasas, 1979; Matsuzama & Hostetler, 1980; Brockman et al., 1980) , of arachidonic acid generation and phagocytosis, indicate a function for this pathway during this process. Although arachidonic acid is the precursor of numerous metabolites, arachidonoyldiacylglycerol is a potential candidate to modulate protein kinase activity, as it has been shown in other systems. (Kishimoto et al., 1980) . With respect to the increased synthesis of PtdCho, its function may be the building of membranes during phagocytosis. If so, PtdEtn, the second most abundant phospholipid within membranes, would not be used for PtdCho synthesis by transmethylation but to build membranes.
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